Literature DB >> 24696261

Interleukin 15 receptor alpha rs2228059 A > C polymorphism decreased risk of gastric cardiac adenocarcinoma in a Chinese population.

Jun Yin1, Chao Liu, Xu Wang, Liming Wang, Yijun Shi, Weifeng Tang, Guowen Ding, Ruiping Liu, Suocheng Chen, Haiyong Gu, Liang Zheng.   

Abstract

Gastric cardiac adenocarcinoma (GCA) is one of the common malignant tumors in the world and has a high incidence in China. Both environmental risk factors and genetic factors might play an essential role in the GCA carcinogenesis. We performed a hospital-based case-control study to evaluate the genetic effects of interleukin 15 (IL15) and IL15 receptor alpha (IL15RA) functional single nucleotide polymorphisms (SNPs) on the pathogenesis of GCA. A total of 243 GCA cases and 476 controls were enrolled in this study. The genotypes were determined using a custom-by-design 48-Plex SNPscan(TM) Kit. When the IL15RA rs2228059 AA homozygote genotype was used as the reference group, the CC genotype was correlated with a significantly decreased risk for GCA (CC vs. AA: adjusted OR = 0.61, 95 % CI = 0.37-0.98, p = 0.042). Our results revealed that functional variant IL15RA rs2228059 A > C might attenuate individual's risk of GCA. However, there was no significant association between the other five IL15 SNPs and GCA susceptibility. This present study demonstrated that IL15RA rs2228059 A > C polymorphism might modify GCA susceptibility. The results were based on a limited sample size; future larger studies with more rigorous designs are warranted to validate our findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696261     DOI: 10.1007/s13277-014-1872-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.

Authors:  Weimin Zhang; Chen Li; Jing Wang; Chao He
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

2.  B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population.

Authors:  Qiong Li; Jun Yin; Xu Wang; Li-Ming Wang; Yi-Jun Shi; Liang Zheng; Wei-Feng Tang; Guo-Wen Ding; Chao Liu; Rui-Ping Liu; Hai-Yong Gu; Jia-Ming Sun; Suo-Cheng Chen
Journal:  Asian Pac J Cancer Prev       Date:  2013

3.  IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.

Authors:  Georgia Malamut; Raja El Machhour; Nicolas Montcuquet; Séverine Martin-Lannerée; Isabelle Dusanter-Fourt; Virginie Verkarre; Jean-Jacques Mention; Gabriel Rahmi; Hiroshi Kiyono; Eric A Butz; Nicole Brousse; Christophe Cellier; Nadine Cerf-Bensussan; Bertrand Meresse
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  Peptidylarginine deiminase type 4 and methyl-CpG binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis.

Authors:  Jinluo Cheng; Hui Zhang; Chao Zhuang; Ruiping Liu
Journal:  J Rheumatol       Date:  2012-04-15       Impact factor: 4.666

5.  MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population.

Authors:  Jishu Wei; Liang Zheng; Shenghua Liu; Jun Yin; Liming Wang; Xu Wang; Yijun Shi; Aizhong Shao; Weifeng Tang; Guowen Ding; Chao Liu; Suocheng Chen; Haiyong Gu
Journal:  Hum Immunol       Date:  2013-06-17       Impact factor: 2.850

6.  Expression of interleukin 15 in primary adult acute lymphoblastic leukemia.

Authors:  Shuling Wu; Lars Fischer; Nicola Gökbuget; Stefan Schwartz; Thomas Burmeister; Michael Notter; Dieter Hoelzer; Hendrik Fuchs; Igor Wolfgang Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

7.  The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.

Authors:  Cécile Badoual; Grégory Bouchaud; Nour El Houda Agueznay; Erwan Mortier; Stéphane Hans; Alain Gey; Fahima Fernani; Séverine Peyrard; Pierre Laurent -Puig; Patrick Bruneval; Xavier Sastre; Ariane Plet; Laure Garrigue-Antar; Françoise Quintin-Colonna; Wolf H Fridman; Daniel Brasnu; Yannick Jacques; Eric Tartour
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

8.  High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.

Authors:  Gunnar Cario; Shai Izraeli; Anja Teichert; Peter Rhein; Julia Skokowa; Anja Möricke; Martin Zimmermann; Andre Schrauder; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Welte; Holger J Schünemann; Brigitte Schlegelberger; Martin Schrappe; Martin Stanulla
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

9.  Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.

Authors:  L Trentin; A Cerutti; R Zambello; R Sancretta; C Tassinari; M Facco; F Adami; F Rodeghiero; C Agostini; G Semenzato
Journal:  Blood       Date:  1996-04-15       Impact factor: 22.113

10.  Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

Authors:  Masahiro Seike; Nozomu Yanaihara; Elise D Bowman; Krista A Zanetti; Anuradha Budhu; Kensuke Kumamoto; Leah E Mechanic; Shingo Matsumoto; Jun Yokota; Tatsuhiro Shibata; Haruhiko Sugimura; Akihiko Gemma; Shoji Kudoh; Xin W Wang; Curtis C Harris
Journal:  J Natl Cancer Inst       Date:  2007-08-08       Impact factor: 13.506

View more
  2 in total

1.  Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma.

Authors:  Weifeng Tang; Yu Chen; Shuchen Chen; Bin Sun; Haiyong Gu; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Lack of association between cyclin D1 A870G (rs9344) polymorphism and esophageal squamous cell carcinoma risk: case-control study and meta-analysis.

Authors:  Weifeng Tang; Ping Yu; Yafeng Wang; Mingqiang Kang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.